NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

In one post I read the poster had the opinion that with the issuance of the Journal we'd get all the publicity we'd ever need to market DCVax-L all over the world. I will agree that such a Journal is important, but it's not and end all, be all. Certainly it will reach a lot of professionals, but I don't believe that anywhere near all the patients who could benefit from DCVax-L will not hear of it. I don't care how much great press the Journal gets, to continually grow the size of the user base, it will always need more.

As approvals come in NWBO will either need to build it's own staff to distribute and sell DCVax-L or it will need contractors or partners serving in that capacity. It will be up to the company, or it's partners to manage the growth in annual sales and assure that production can meet the demand for DCVax-L. If in fact off label use of DCVax-L grows rapidly and anecdotal evidence validates that growth as being effective in many cancers the demand could easily meet double digit billions very rapidly. If we had 2 billion shares outstanding and 20, 30, 40 billion or more dollar sales with anticipated growth ranging in mid double digit percentages annually, what would a fair P/E be for NWBO stock. How long will it take to reach triple digits.

Gary